- Oil prices extend gains on Mideast tensions, Wall Street falls
- 'Dark day': Victims mourned around the globe on Oct. 7 anniversary
- Mission to probe smashed asteroid launches despite hurricane
- Oil prices extend gains on Mideast tensions, Wall Street slips
- Europe's asteroid mission Hera launches despite hurricane
- Oil prices extend gains on Mideast tensions, Wall Street retreats
- What is microRNA? Nobel-winning discovery explained
- Weather may delay launch of mission to study deflected asteroid
- China to flesh out economic stimulus plans after bumper rally
- Asian markets track Wall St rally on US jobs data
- World marks anniversary of Oct. 7 attack on Israel
- Asian markets track Wall St rally on jobs data
- Cancer, cardiovascular drugs tipped for Nobel as prize week opens
- Tunisia incumbent Saied set to win presidential vote: exit polls
- 'Difficult day': Oct 7 commemorations begin with festival memorial
- Commemorations begin for anniversary of attack on Israel
- Tunisia voting ends as Saied eyes re-election with critics behind bars
- Drowned by hurricane, remote N.Carolina towns now struggle for water
- Two elephants die in flash flooding in northern Thailand
- Tunisia votes with Saied set for re-election
- Too hot by day, Dubai's floodlit beaches are packed at night
- A 'forgotten' valley in storm-hit North Carolina, desperate for help
- Italy targets climate activists in 'anti-Gandhi' demo clampdown
- US trade chief defends tariff hikes when paired with investment
- EU court blocks French ban on vegetable 'steak' labelling
- Meta AI turns pictures into videos with sound
- US dockworkers return to ports after three-day strike
- DR Congo to begin mpox vaccination campaign Saturday in east
- Meta must limit data use for targeted ads: EU court
- Oil extends gains, jobs report lifts Wall Street
- US hiring soars past expectations in sign of resilient market
- As EU targets Chinese cars, European rivals sputter
- Top EU court finds against FIFA in key transfer market ruling
- Oil extends gains, Hong Kong stocks resume rally
- 'A man provides': Ukrainian miners send families away as Russia advances
- EU states greenlight extra tariffs on EVs from China
- Hong Kong stocks resume rally, oil dips after Middle East-fuelled surge
- Crude stable after Israel-Iran surge, Hong Kong stocks resume gains
- Hera spacecraft to probe asteroid deflected by defence test
- US dockworkers to head back to work after tentative deal
- After Helene's destruction, North Carolina starts to rebuild
- Dockers end three-day strike at Montreal port
- What next for OpenAI after $157 billion bonanza?
- Israel-Hamas war causes 86-percent dive in Gaza GDP: IMF
- Milan's Morata moves house after Inter-fan town mayor 'violates' privacy
- 'Devastating' storm hits Augusta National but Masters will go on
- Relief in Brazil, Asia over delay to EU deforestation rules
- Oil prices jump, stocks fall on Middle East tensions
- Biden says 'discussing' possible Israeli strikes on Iran oil facilities
- Oil prices rise, stocks fall on Middle East tensions
RBGPF | -1.97% | 58.94 | $ | |
JRI | -0.76% | 13.18 | $ | |
BCC | 1.68% | 141.27 | $ | |
RYCEF | -1.45% | 6.88 | $ | |
NGG | -1.56% | 65.48 | $ | |
SCS | -0.15% | 12.95 | $ | |
CMSC | -0.53% | 24.57 | $ | |
RELX | -0.54% | 46.04 | $ | |
RIO | -0.11% | 69.62 | $ | |
GSK | -0.49% | 38.63 | $ | |
BCE | -0.54% | 33.53 | $ | |
BTI | -0.26% | 35.2 | $ | |
AZN | -0.78% | 76.87 | $ | |
VOD | 0.31% | 9.69 | $ | |
BP | 0.78% | 33.14 | $ | |
CMSD | -0.09% | 24.79 | $ |
Medical community frets over fate of Twitter
For days, doctors, scientists and public health experts have been telling their Twitter followers where to find them on other platforms if Elon Musk's newly-acquired company tanks.
The social media giant symbolized by the blue bird has laid off half of its 7,500 employees, while several hundred others have resigned, creating doubts over its future.
Even if it survives, the unpredictability of the new boss has raised fears his policies could profoundly alter the character of the so-called digital town square.
That would be a deep loss for medical experts, who have used Twitter since the start of the Covid pandemic as a tool to quickly gather information, share their research, communicate public health messages and forge new collaborations.
The pandemic was a "tipping point for the use of social media as a primary resource for researchers," Jason Kindrachuk, a virologist at the University of Manitoba in Canada, told AFP.
As the coronavirus began its global march in January 2020, researchers embarked on studies to understand how the virus spreads, its health effects, and how best to protect oneself.
They shared findings immediately on Twitter to assist the wider medical community and an anxious public, often in the form of "preprints" -- early versions of scientific papers before they are submitted to a journal.
"In the middle of a pandemic, the ability to rapidly share information is critical for knowledge translation and dissemination, and Twitter is able to do this in a way that is typically not feasible for textbooks or journals," said a commentary published in the Canadian Journal of Emergency Medicine.
The process of peer review effectively took place in real time on Twitter, with scientists publicly sharing their interpretations and critiques of each new study.
Of course, there was also a downside: unworthy work received outsized attention, and non-specialists held forth on subjects far from their areas of expertise.
- International collaborations -
On the other hand, it was thanks to Twitter that experts from around the world were able to find one another easily and team up.
"There are people that I collaborate with now that have been based on interactions that were born out of Twitter," said Kindrachuk, who has around 22,000 followers.
"To think that that could change in the very near future, that to me does kind of bring some feelings of concern and regret."
For example, it was the vital work of researchers from South Africa and Botswana that alerted the world to the dangerous Omicron variant in late 2021.
The loss of Twitter would be compounded by the fact it has long been frequented by experts of another profession: journalism.
"Because Twitter is a platform that is followed by a lot of journalists, it helps, there's a feedback loop. It gets amplified," explained Celine Gounder, an infectious disease specialist and epidemiologist with 88,000 followers.
She added she had moved a private Twitter discussion with a dozen colleagues to Signal, and started once more posting her thoughts to LinkedIn as well as the Post News platform.
Many experts have now put their handles on rival service Mastodon on their Twitter bios, or directed their followers to their newsletters on Substack.
If Twitter doesn't work out, "we will all adapt, we will find other social media platforms," said Kindrachuk.
"But it will take time and unfortunately, infectious diseases don't wait for us to find new mechanisms to communicate."
Y.Ibrahim--CPN